NCT06439485
- Conditions
- Advanced Cholangiocarcinoma, FGFR2 Fusion
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Advanced Cholangiocarcinoma
Explore clinical trials studying Advanced Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
8 public trials
5 recruiting studies
Advanced Cholangiocarcinoma trial results
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176
- Conditions
- Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +6 more
- Locations
-
- University of California San Diego UCSD - Moores Cancer Center La Jolla, California, United States
- Tampa General Hospital Cancer Institute Tampa, Florida, United States
- Henry Ford Health System Detroit, Michigan, United States
- Gabrail Cancer Center Research Canton, Ohio, United States
Recruiting
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT05969860
- Conditions
- Advanced Anal Carcinoma, Advanced Appendix Carcinoma, Advanced Basal Cell Carcinoma, +57 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Altru Cancer Center Grand Forks, North Dakota, United States
NCT05532059
- Conditions
- Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +4 more
- Locations
-
- The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT05823311
- Conditions
- Advanced Cholangiocarcinoma
- Locations
-
- The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT07328919
- Conditions
- Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +6 more
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
Completed
Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)
NCT02989857
- Conditions
- Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +5 more
- Locations
-
- Mayo Cancer Center Scottsdale, Arizona, United States
- City of Hope Cancer Center Duarte, California, United States
- University of California, Irvine Irvine, California, United States
- University of Southern California Los Angeles, California, United States
NCT05791448
- Conditions
- Adenocarcinoma, Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, +15 more
- Locations
-
- Los Angeles County-USC Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States